BMEA — Biomea Fusion Share News
0.000.00%
Last trade - 00:00Biomea Fusion plunges on $25 mln stock-and-warrants offering
Brief: Biomea Fusion Announces Pricing Of Public Offering Of Securities
Brief: Biomea Fusion Announces Proposed Public Offering Of Securities
Biomea's diabetes drug shows promise, may work for those responding to GLP-1
Brief: Biomea Announces Positive 52-Week Results From Phase II COVALENT-111 Study In Type 2 Diabetes
Brief: Biomea Fusion, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity Of Icovamenib In Combination With Semaglutide In Type 2 Diabetes (T2d) Animal Model At The 61St Easd Annual Meeting And Provides Additional Corporate Update
Biomea Fusion Inc reports results for the quarter ended June 30 - Earnings Summary
Biomea Fusion Q2 net loss narrows to $20.7 mln
Brief: Biomea Fusion Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing
Biomea Fusion Inc expected to post a loss of 53 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SanDisk, MakeMyTrip, Coinbase
U.S. STOCKS ON THE MOVE-Affirm, Guild Holdings, Circle Internet
U.S. STOCKS ON THE MOVE-Circle, Guild Holdings, Steel Dynamics
U.S. STOCKS ON THE MOVE-Bitdeer, Biomea Fusion, Circle Internet
Biomea Fusion tumbles on deep-discounted $40 mln equity raise
Brief: Biomea Fusion Announces Pricing Of Public Offering Of Securities
Biomea Fusion tumbles on planned equity offering
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G